Fuzeon

Manufacturing · Australia · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Australia

Revenue

$5.9 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Fuzeon

Fuzeon offers FUZEON® (enfuvirtide), an injection treatment for HIV-1 infection intended for patients who have experienced treatment failure with other antiretroviral medications. The company provides comprehensive resources including dosing instructions, safety information, and tips for managing HIV infection effectively. Intended clients are individuals living with HIV-1, along with healthcare providers who support these patients. Fuzeon emphasizes patient support and education as key components in the treatment journey.Explore more
Fuzeon's Social MediaPopular SearchesFuzeonSIC Code 28,283NAICS Code 32,325Show more

Is Fuzeon your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Fuzeon

Compare insights from companies similar to Fuzeon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Fuzeon

$5.9M
11-50
Private
-
-
N/A
$5.8M
11-50
Private
-
2006
KW
Kavindu WickramasingheQuality and Regulatory Personnel
$5.6M
11-50
Private
-
-
EV
Emma VanheemsPosition In Chinese Medicine and Acupuncture
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Fuzeon is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Fuzeon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fuzeon.

Fuzeon Tech Stack

A closer look at the technologies used by Fuzeon

See more technologies

Top Manufacturing Companies

Frequently Asked Questions Regarding Fuzeon

What is Fuzeon's official website?
Fuzeon's official website is www.fuzeon.com
What is Fuzeon's Revenue?
Fuzeon's revenue is $5.9 Million
What is Fuzeon's SIC code?
Fuzeon's SIC: 28,283
What is Fuzeon's NAICS code?
Fuzeon's NAICS: 32,325
How many employees does Fuzeon have?
Fuzeon has 11-50 employees
What industry does Fuzeon belong to?
Fuzeon is in the industry of: Manufacturing, Pharmaceuticals
What is Fuzeon competition?
Fuzeon top competitors include: Neuromagnetics Australia, Metsal, Rare Earth Oils, ReachHealth
What technology does Fuzeon use?
Some of the popular technologies that Fuzeon uses are: Cloudflare DNS
What does Fuzeon do?

Fuzeon offers FUZEON® (enfuvirtide), an injection treatment for HIV-1 infection intended for patients who have experienced treatment failure with other antiretroviral medications. The company provides comprehensive resources including dosing instructions, safety information, and tips for managing HIV infection effectively. Intended clients are indi... viduals living with HIV-1, along with healthcare providers who support these patients. Fuzeon emphasizes patient support and education as key components in the treatment journey.Read More

What are Fuzeon social media links?
Fuzeon Twitter page
Is Fuzeon a public company?
Fuzeon is private company therefore does not currently have an official ticker symbol
See more information about Fuzeon

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.